Selected research
Industry Research
Prescription Weight Loss Pills Industry Research Report 2026
Market perspective
The global Prescription Weight Loss Pills market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prescription Weight Loss Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prescription Weight Loss Pills is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prescription Weight Loss Pills is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prescription Weight Loss Pills include Teva Pharmaceutical (Actavis), Sanofi (Adlyxin), Novo Nordisk A/S, Eli Lilly and Company (TRICARE), Pfizer, AstraZeneca (BYDUREON BCise), VIVUS (Qsymia), Rhythm Pharmaceuticals (Imcivree) and Haleon Group (alli), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prescription Weight Loss Pills market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prescription Weight Loss Pills Market by Company
Teva Pharmaceutical (Actavis)
Sanofi (Adlyxin)
Novo Nordisk A/S
Eli Lilly and Company (TRICARE)
Pfizer
AstraZeneca (BYDUREON BCise)
VIVUS (Qsymia)
Rhythm Pharmaceuticals (Imcivree)
Haleon Group (alli)
Currax Pharmaceuticals (Contrave)
CHEPLAPHARM (Xenical)
Prescription Weight Loss Pills Segment by Type
Injections
Oral Tablets
Oral Capsules
Prescription Weight Loss Pills Segment by Application
Hospital
Pharmacy
Prescription Weight Loss Pills Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Weight Loss Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prescription Weight Loss Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Weight Loss Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prescription Weight Loss Pills manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prescription Weight Loss Pills by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prescription Weight Loss Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injections
- Oral Tablets
- Oral Capsules
Applications
- Hospital
- Pharmacy
Companies covered
- Teva Pharmaceutical (Actavis)
- Sanofi (Adlyxin)
- Novo Nordisk A/S
- Eli Lilly and Company (TRICARE)
- Pfizer
- AstraZeneca (BYDUREON BCise)
- VIVUS (Qsymia)
- Rhythm Pharmaceuticals (Imcivree)
- Haleon Group (alli)
- Currax Pharmaceuticals (Contrave)
- CHEPLAPHARM (Xenical)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prescription Weight Loss Pills Market Size (2021-2032)
- 2.2.2 Global Prescription Weight Loss Pills Sales (2021-2032)
- 2.2.3 Global Prescription Weight Loss Pills Market Average Price (2021-2032)
- 2.3 Prescription Weight Loss Pills by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injections
- 2.3.3 Oral Tablets
- 2.3.4 Oral Capsules
- 2.4 Prescription Weight Loss Pills by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prescription Weight Loss Pills Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prescription Weight Loss Pills Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Prescription Weight Loss Pills Revenue of Manufacturers (2021-2026)
- 3.4 Global Prescription Weight Loss Pills Average Price by Manufacturers (2021-2026)
- 3.5 Global Prescription Weight Loss Pills Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prescription Weight Loss Pills, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prescription Weight Loss Pills, Product Type & Application
- 3.8 Global Manufacturers of Prescription Weight Loss Pills, Established Date
- 3.9 Global Prescription Weight Loss Pills Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva Pharmaceutical (Actavis)
- 4.1.1 Teva Pharmaceutical (Actavis) Company Information
- 4.1.2 Teva Pharmaceutical (Actavis) Business Overview
- 4.1.3 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Pharmaceutical (Actavis) Prescription Weight Loss Pills Product Portfolio
- 4.1.5 Teva Pharmaceutical (Actavis) Recent Developments
- 4.2 Sanofi (Adlyxin)
- 4.2.1 Sanofi (Adlyxin) Company Information
- 4.2.2 Sanofi (Adlyxin) Business Overview
- 4.2.3 Sanofi (Adlyxin) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi (Adlyxin) Prescription Weight Loss Pills Product Portfolio
- 4.2.5 Sanofi (Adlyxin) Recent Developments
- 4.3 Novo Nordisk A/S
- 4.3.1 Novo Nordisk A/S Company Information
- 4.3.2 Novo Nordisk A/S Business Overview
- 4.3.3 Novo Nordisk A/S Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Novo Nordisk A/S Prescription Weight Loss Pills Product Portfolio
- 4.3.5 Novo Nordisk A/S Recent Developments
- 4.4 Eli Lilly and Company (TRICARE)
- 4.4.1 Eli Lilly and Company (TRICARE) Company Information
- 4.4.2 Eli Lilly and Company (TRICARE) Business Overview
- 4.4.3 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eli Lilly and Company (TRICARE) Prescription Weight Loss Pills Product Portfolio
- 4.4.5 Eli Lilly and Company (TRICARE) Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Prescription Weight Loss Pills Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 AstraZeneca (BYDUREON BCise)
- 4.6.1 AstraZeneca (BYDUREON BCise) Company Information
- 4.6.2 AstraZeneca (BYDUREON BCise) Business Overview
- 4.6.3 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AstraZeneca (BYDUREON BCise) Prescription Weight Loss Pills Product Portfolio
- 4.6.5 AstraZeneca (BYDUREON BCise) Recent Developments
- 4.7 VIVUS (Qsymia)
- 4.7.1 VIVUS (Qsymia) Company Information
- 4.7.2 VIVUS (Qsymia) Business Overview
- 4.7.3 VIVUS (Qsymia) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 VIVUS (Qsymia) Prescription Weight Loss Pills Product Portfolio
- 4.7.5 VIVUS (Qsymia) Recent Developments
- 4.8 Rhythm Pharmaceuticals (Imcivree)
- 4.8.1 Rhythm Pharmaceuticals (Imcivree) Company Information
- 4.8.2 Rhythm Pharmaceuticals (Imcivree) Business Overview
- 4.8.3 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Rhythm Pharmaceuticals (Imcivree) Prescription Weight Loss Pills Product Portfolio
- 4.8.5 Rhythm Pharmaceuticals (Imcivree) Recent Developments
- 4.9 Haleon Group (alli)
- 4.9.1 Haleon Group (alli) Company Information
- 4.9.2 Haleon Group (alli) Business Overview
- 4.9.3 Haleon Group (alli) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Haleon Group (alli) Prescription Weight Loss Pills Product Portfolio
- 4.9.5 Haleon Group (alli) Recent Developments
- 4.10 Currax Pharmaceuticals (Contrave)
- 4.10.1 Currax Pharmaceuticals (Contrave) Company Information
- 4.10.2 Currax Pharmaceuticals (Contrave) Business Overview
- 4.10.3 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Currax Pharmaceuticals (Contrave) Prescription Weight Loss Pills Product Portfolio
- 4.10.5 Currax Pharmaceuticals (Contrave) Recent Developments
- 4.11 CHEPLAPHARM (Xenical)
- 4.11.1 CHEPLAPHARM (Xenical) Company Information
- 4.11.2 CHEPLAPHARM (Xenical) Business Overview
- 4.11.3 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 CHEPLAPHARM (Xenical) Prescription Weight Loss Pills Product Portfolio
- 4.11.5 CHEPLAPHARM (Xenical) Recent Developments
5 Global Prescription Weight Loss Pills Market Scenario by Region
- 5.1 Global Prescription Weight Loss Pills Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prescription Weight Loss Pills Sales by Region: 2021-2032
- 5.2.1 Global Prescription Weight Loss Pills Sales by Region: 2021-2026
- 5.2.2 Global Prescription Weight Loss Pills Sales by Region: 2027-2032
- 5.3 Global Prescription Weight Loss Pills Revenue by Region: 2021-2032
- 5.3.1 Global Prescription Weight Loss Pills Revenue by Region: 2021-2026
- 5.3.2 Global Prescription Weight Loss Pills Revenue by Region: 2027-2032
- 5.4 North America Prescription Weight Loss Pills Market Facts & Figures by Country
- 5.4.1 North America Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prescription Weight Loss Pills Sales by Country (2021-2032)
- 5.4.3 North America Prescription Weight Loss Pills Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Prescription Weight Loss Pills Market Facts & Figures by Country
- 5.5.1 Europe Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prescription Weight Loss Pills Sales by Country (2021-2032)
- 5.5.3 Europe Prescription Weight Loss Pills Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Prescription Weight Loss Pills Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prescription Weight Loss Pills Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prescription Weight Loss Pills Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prescription Weight Loss Pills Market Facts & Figures by Country
- 5.7.1 South America Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prescription Weight Loss Pills Sales by Country (2021-2032)
- 5.7.3 South America Prescription Weight Loss Pills Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Prescription Weight Loss Pills Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prescription Weight Loss Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prescription Weight Loss Pills Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prescription Weight Loss Pills Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Prescription Weight Loss Pills Sales by Type (2021-2032)
- 6.1.1 Global Prescription Weight Loss Pills Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Prescription Weight Loss Pills Sales Market Share by Type (2021-2032)
- 6.2 Global Prescription Weight Loss Pills Revenue by Type (2021-2032)
- 6.2.1 Global Prescription Weight Loss Pills Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prescription Weight Loss Pills Revenue Market Share by Type (2021-2032)
- 6.3 Global Prescription Weight Loss Pills Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prescription Weight Loss Pills Sales by Application (2021-2032)
- 7.1.1 Global Prescription Weight Loss Pills Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Prescription Weight Loss Pills Sales Market Share by Application (2021-2032)
- 7.2 Global Prescription Weight Loss Pills Revenue by Application (2021-2032)
- 7.2.1 Global Prescription Weight Loss Pills Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prescription Weight Loss Pills Revenue Market Share by Application (2021-2032)
- 7.3 Global Prescription Weight Loss Pills Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prescription Weight Loss Pills Value Chain Analysis
- 8.1.1 Prescription Weight Loss Pills Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prescription Weight Loss Pills Production Mode & Process
- 8.2 Prescription Weight Loss Pills Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prescription Weight Loss Pills Distributors
- 8.2.3 Prescription Weight Loss Pills Customers
9 Global Prescription Weight Loss Pills Analyzing Market Dynamics
- 9.1 Prescription Weight Loss Pills Industry Trends
- 9.2 Prescription Weight Loss Pills Industry Drivers
- 9.3 Prescription Weight Loss Pills Industry Opportunities and Challenges
- 9.4 Prescription Weight Loss Pills Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst